DocStoX is a free AI-powered research platform for Indian equity markets, covering 5,700+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (5,700+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 93 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactCompany

Mangalam Drugs And Organics Limited — Certificate under SEBI (Depositories and Participants) Regulations, 2018

NSE 56 min ago·7 Oct 2026, 7:41 am

Company NSE

Mangalam Drugs And Organics Limited has informed stock exchanges that it has obtained a certificate under SEBI's Depositories and Participants Regulations, 2018. This document confirms that the company has complied with all necessary regulatory requirements for its depository activities.

For investors, this update is largely procedural. It signifies that the company's internal systems and processes for handling securities are in order and meet current regulatory standards. Such compliance is a standard requirement for listed entities to ensure smooth operations and transparency in the market.

Moving forward, investors should monitor the company's regular financial disclosures. While this specific regulatory filing is routine, it reinforces the company's adherence to corporate governance norms. Watch for any further announcements regarding the company's operational performance or future business developments.